Boundless Bio Inc narrowed first quarter of 2025 net loss per share of $-0.71 compare to net loss per share of $-12.27 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.73 realized in previous quarter.
first quarter of 2025
Earnings Per Share
Revenues
$ -0.71
$
0 Mill
$+11.56
Unch.
Boundless Bio Inc 's Revenue
fell by
0 % in first quarter of 2025 (Mar 31 2025) year on year,
to $0 million and
declined by
sequentially.
Boundless Bio Inc in the first quarter of 2025 recorded net loss of $-15.758 million, an increase from net loss of $-15.430 million in I. Quarter a year ago.
Sequentially
net loss narrowed from net loss of $-16.448 million realized in previous quarter.
Boundless Bio Inc Inventories
In Mar 31 2025 company's net cash and cash equivalents decreased by $-11 million, capital expenditures grew by -0.083-28.92%, to $0 millions compare to same quarter a year ago
Boundless Bio Inc
does not pay out common stock dividend.
In trailing twelve-month period Boundless Bio Inc payed $ -2.67 cash per share, on a free-cash flow basis
.
Book value fell by -30.97 % sequentially to $6.13 per share, -93.01% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 6.13 per share from $ 8.87.
Company
issued 5.32 million shares or 31.35 % in Mar 31 2025.
Boundless Bio Inc
does not pay out common stock dividend.
In trailing twelve-month period Boundless Bio Inc had negative $ -2.67 cash flow per share, on a free-cash flow basis
.
Book value fell by -30.97 % sequentially to $6.13 per share, -93.01% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 6.13 per share from $ 8.87.
Company
issued 5.32 million shares or 31.35 % in Mar 31 2025.
